MK

Mithlesh Kumari

Active Director Director DIN 10076835
DIN 10076835 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Mithlesh Kumari

Data last updated:

Mithlesh Kumari is a Director at Puerile Dermaceuticals Private Limited (since 2023). Puerile Dermaceuticals Private Limited reported revenue of ₹46.4 Lakh (FY 2025).

DIN 10076835
Primary Designation Director
First Appointment 17 Mar 2023
Oldest Company Age 3 yrs
Largest company Puerile Dermaceuticals Private Limited · ₹46.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Mar 20232023₹46.4 Lakh (FY 2025)Active

Board colleagues of Mithlesh Kumari

NameDINCompanyDesignation
Vivek Singh Kushwah10076836Puerile Dermaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Puerile Dermaceuticals Private Limited
Premium access

Shareholding and investment profile for Mithlesh Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mithlesh Kumari

Mithlesh Kumari currently holds 1 directorship: Puerile Dermaceuticals Private Limited (Director, since 17 Mar 2023, revenue ₹46.4 Lakh (FY 2025)).

Mithlesh Kumari was first appointed on 17 Mar 2023 as Director at Puerile Dermaceuticals Private Limited.

The current boards of Mithlesh Kumari's companies include Vivek Singh Kushwah (Puerile Dermaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available